The effect of exposure to thiazolidinediones on the development of head-and-neck cancer in patients with diabetes mellitus
Background: Thiazolidinediones (TZDs) are proliferator-activated receptor-γ (PPAR-γ) ligands with a variety of metabolic activities approved for the treatment of type 2 diabetes mellitus. In addition to being potent hypoglycemic agents, they are recognized through in-vitro studies as having antiprol...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SAGE Publishing
2017-11-01
|
| Series: | Translational Research in Oral Oncology |
| Online Access: | https://doi.org/10.1177/2057178X17739809 |